Aeglea Biotherapeutics shares owned by Affinity Asset Advisors
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Affinity Asset Advisors
from 13F filings
Historical chart of Affinity Asset Advisors investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Affinity Asset Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $24M | 1.4M | 16.76 |
| 2025-06-30 | $9.1M | 607k | 14.97 |
| 2025-03-31 | $7.8M | 482k | 16.14 |
| 2024-12-31 | $19M | 824k | 23.28 |
| 2024-09-30 | $15M | 498k | 29.41 |
| 2024-06-30 | $12M | 513k | 23.51 |
| 2024-03-31 | $16M | 410k | 37.93 |
| 2023-12-31 | $11M | 518k | 21.52 |
| 2023-09-30 | $3.0M | 242k | 12.25 |